|
Cytochrome P-450 CYP2C8 Inhibitors
|
D27.505.519.389.335.308 |
|
|
3-Hydroxysteroid Dehydrogenases
|
D08.811.682.047.436.350 |
|
|
Lutheran Blood-Group System
|
D23.050.301.290.552 |
|
|
Blood Group Antigens
|
D23.050.301.290 |
|
|
Mitochondria, Heart
|
A11.284.835.626.627.603 |
|
|
Enterocolitis, Neutropenic
|
C06.405.205.596.750 |
|
|
Enterocolitis
|
C06.405.205.596 |
|
|
Proteasome Inhibitors
|
D27.505.519.389.745.705 |
|
|
Infrared Rays
|
G01.750.770.578.552 |
|
|
Light
|
G01.750.770.578 |
|
|
Prolactin-Releasing Hormone
|
D12.644.400.400.967 |
|
|
Hypothalamic Hormones
|
D12.644.400.400 |
|
|
Lysosomal-Associated Membrane Protein 2
|
D052119 |
[An abundant lysosomal-associated membrane protein that has been found to shuttle between LYSOSOMES; ENDOSOMES; and the PLASMA MEMBRANE. Loss of expression of lysosomal-associated membrane protein 2 is associated with GLYCOGEN STORAGE DISEASE TYPE IIB.
] |
|
Ondansetron
|
D03.633.100.473.144.500 |
|
|
Cholesterol Side-Chain Cleavage Enzyme
|
D12.776.422.220.453.484.250 |
|
|
Adrenal Hyperplasia, Congenital
|
C16.131.939.316.129.500 |
|
|
Adrenogenital Syndrome
|
C16.131.939.316.129 |
|
|
Vaccines, Virus-Like Particle
|
D20.215.894.865.955 |
|
|
Periostitis
|
C05.116.165.595 |
|
|
Bone Diseases, Infectious
|
C05.116.165 |
|
